Financhill
Back

CSL Quote, Financials, Valuation and Earnings

CSL Price Quote

$86.54

CSL Key Stats

Sell
23
CSL (CSLLY) is a Sell

Day range:
$83.31 - $87.34
52-week range:
$83.31 - $109.00
Dividend yield:
1.53%
P/E ratio:
31.76
P/S ratio:
5.71
P/B ratio:
4.83%

Volume:
75.8K
Avg. volume:
90.7K
1-year change:
-8.64%
Market cap:
$83.8B
Revenue:
$14.7B
EPS:
$2.73

How Much Does CSL Make?

Data Unavailable

Is CSL Growing As A Company?

Data Unavailable

CSL Stock Price Performance

  • Did CSL Stock Go Up Last Month?
    CSL share price went down by -2.47% last month
  • Did CSLLY's Share Price Rise Over The Last Year?
    CSLLY share price fell by -8.64% over the past 1 year

What Is CSL 52-Week High & Low?

  • What Is CSL’s 52-Week High Share Price?
    CSL has traded as high as $109.00 over the past 52 weeks
  • What Is CSL’s 52-Week Low Share Price?
    CSL has traded as low as $83.31 over the past 52 weeks

CSL Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CSL?

Data Unavailable

Is CSL Cash Flow Positive?

Data Unavailable

CSL Return On Invested Capital

Data Unavailable

CSL Earnings Date & Stock Price

  • What Is CSL's Stock Price Today?
    A single share of CSLLY can be purchased today for 86.54
  • What Is CSL’s Stock Symbol?
    CSL trades on the otcm under the ticker symbol: CSLLY
  • When Is CSL’s Next Earnings Date?
    The next quarterly earnings date for CSL is scheduled on February 13, 2025
  • When Is CSLLY's next ex-dividend date?
    CSL's next ex-dividend date is September 10, 2024
  • How To Buy CSL Stock?
    You can buy CSL shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

CSL Competitors

  • Who Are CSL's Competitors?
    Below is a list of companies who compete with CSL or are related in some way:
    • Alterity Therapeutics Ltd (ATHE)
    • Immutep Ltd (IMMP)
    • Kazia Therapeutics Ltd (KZIA)
    • Mesoblast Ltd (MESO)
    • Opthea Ltd (OPT)

CSL Dividend Yield

Data Unavailable

CSL Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable